1. 1Oncology and Urology, Hopkins Kimmel Cancer Center, Baltimore, Maryland.
2. 2Phase 1 Clinical Trials Program, Henry Ford Cancer Institute, Detroit, Michigan.
3. 3Biostatistics, the healthcare business of Merck KGaA, Darmstadt, Germany.
4. 4Clinical Pharmacology, the healthcare business of Merck KGaA, Darmstadt, Germany.
5. 5Pharmacokinetics, the healthcare business of Merck KGaA, Darmstadt, Germany.
6. 6Clinical Biomarkers, the healthcare business of Merck KGaA, Darmstadt, Germany.
7. 7Safety Strategy, Olexacon Ltd., London, United Kingdom.
8. 8Clinical Development, the healthcare business of Merck KGaA, Darmstadt, Germany.
9. 9Medical Oncology, Yale University, New Haven, Connecticut.